Our results showed both an increase in lipid peroxidation marker MDA levels (Figure 6) and a 1.5-fold increase in Bax/Bcl-xL ratio (Figure 7E) indicating an apoptosis switch triggered in melanoma tissue by the sequential treatment. The gene discussed is BCL2L1; the disease is melanoma.